Bill Sponsor
House Bill 5687
115th Congress(2017-2018)
SOUND Disposal and Packaging Act
Active
Active
Passed House on Jun 19, 2018
Overview
Text
Introduced
May 7, 2018
Latest Action
Jun 20, 2018
Origin Chamber
House
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
5687
Congress
115
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
Sponsorship by Party
Republican
North Carolina
Republican
Kentucky
Democrat
North Carolina
Republican
North Carolina
House Votes (1)
Senate Votes (0)
checkPassed on June 19, 2018
Question
On Motion to Suspend the Rules and Pass, as Amended
Status
Passed
Type
Roll Call Vote
Roll Call Vote
A vote that records the individual position of each Member who voted. Such votes occurring on the House floor (by the "yeas and nays" or by "recorded vote") are taken by electronic device. The Senate has no electronic voting system; in such votes, Senators answer "yea" or "nay" as the clerk calls each name aloud. Each vote is compiled by clerks and receives a roll call number (referenced in Congress.gov as a "Record Vote" [Senate] or "Roll no." [House]).
Roll Call Type
2/3 Yea-And-Nay
Roll Number
269
House Roll Call Votes
Summary

Securing Opioids and Unused Narcotics with Deliberate Disposal and Packaging Act of 2018 or the SOUND Disposal and Packaging Act

This bill amends the Federal Food, Drug, and Cosmetic Act to authorize the Food and Drug Administration to require certain packaging and disposal technologies, controls, or measures to mitigate the risk of abuse or misuse of a drug or a class of drugs.

Text (3)
June 20, 2018
June 19, 2018
Actions (13)
06/20/2018
Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
06/19/2018
Motion to reconsider laid on the table Agreed to without objection.
06/19/2018
On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 342 - 13 (Roll no. 269). (text: CR H5234-5235)
06/19/2018
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 342 - 13 (Roll no. 269).(text: CR H5234-5235)
06/19/2018
Considered as unfinished business. (consideration: CR H5271-5272)
06/19/2018
At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
06/19/2018
DEBATE - The House proceeded with forty minutes of debate on H.R. 5687.
06/19/2018
Considered under suspension of the rules. (consideration: CR H5234-5237)
06/19/2018
Mr. Walden moved to suspend the rules and pass the bill, as amended.
05/09/2018
Ordered to be Reported by Voice Vote.
05/09/2018
Committee Consideration and Mark-up Session Held.
05/07/2018
Referred to the House Committee on Energy and Commerce.
05/07/2018
Introduced in House
Public Record
Record Updated
Jan 11, 2023 1:39:35 PM